A group of VC firms and private individuals has invested €10m in a series-C funding round for Austrian vaccine developer Themis, alongside the Global Health Investment Fund (GHIF).
Deal will enable the online booking platform to expand its operations team and prepare for a US launch
Acquirer is currently investing from its sixth flagship fund, which writes equity cheques of €100-300m
GP buys a 70% stake in insurance business Groupe Premium, investing alongside management
Company will use the fresh capital to support the launch of its new Atlas motorcycle helmet